United Therapeutics Corp Bdr (U2TH34) Stock Price & News

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia

About United Therapeutics Corp Bdr

CEO-

Employees1.4K

Founded1996

HeadquartersSilver Spring, Maryland, United States

SectorBiotechnology

Websiteunither.com

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	799.50M	790.20M	781.50M	783.30M
Cost of goods sold	100.90M	103.40M	133.40M	99.50M
Cost of revenue	100.90M	103.40M	133.40M	99.50M
Research and development expenses	127.50M	139.50M	138.20M	146.30M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	181.80M	189.90M	184.10M	206.70M
Operating expense	309.30M	329.40M	322.30M	353.00M
Total operating expenses	410.20M	432.80M	455.70M	452.50M
Operating income	389.30M	357.40M	325.80M	330.80M
Other non operating income	300.00K	800.00K	15.30M	-100.00K
EBT including unusual items	438.00M	444.00M	318.30M	372.70M
EBT excluding unusual items	433.00M	398.30M	379.90M	359.30M
Income tax expense	99.30M	79.70M	43.40M	39.70M
Effective tax rate	22.67%	17.95%	13.63%	10.65%
Other operating expenses	-	-	-	-
Net income	338.70M	364.30M	274.90M	333.00M
Net profit margin	42.36%	46.10%	35.18%	42.51%
Earnings per share	7.16	7.70	5.82	7.27
Interest and investment income	46.40M	43.20M	41.80M	31.50M
Interest expense	-3.00M	-3.10M	-3.00M	-2.90M
Net interest expenses	43.40M	40.10M	38.80M	28.60M
Depreciation and amortization charges	-	-	-	-
EBITDA	411.20M	380.20M	348.40M	355.00M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything